These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27551242)
1. NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis. Sater RA; Gudesblatt M; Kresa-Reahl K; Brandes DW; Sater P Int J MS Care; 2016; 18(4):177-82. PubMed ID: 27551242 [TBL] [Abstract][Full Text] [Related]
2. The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis. Sater RA; Gudesblatt M; Kresa-Reahl K; Brandes DW; Sater PA Mult Scler J Exp Transl Clin; 2015; 1():2055217315577828. PubMed ID: 28607689 [TBL] [Abstract][Full Text] [Related]
3. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Labuz-Roszak B; Kubicka-Bączyk K; Pierzchała K; Machowska-Majchrzak A; Skrzypek M Neurol Neurochir Pol; 2012; 46(4):309-17. PubMed ID: 23023429 [TBL] [Abstract][Full Text] [Related]
4. Sleep--wake and body core temperature rhythms in multiple sclerosis with fatigue. Vetrugno R; Stecchi S; Scandellari C; Pierangeli G; Sabattini L; D'Angelo R; Provini F; Plazzi G; Cortelli P; Montagna P Clin Neurophysiol; 2007 Jan; 118(1):228-34. PubMed ID: 17095290 [TBL] [Abstract][Full Text] [Related]
5. The influence of polysomnography on the Multiple Sleep Latency Test and other measures of daytime sleepiness. Wichniak A; Geisler P; Tracik F; Crönlein T; Morrissey SP; Zulley J Physiol Behav; 2002 Feb 1-15; 75(1-2):183-8. PubMed ID: 11890966 [TBL] [Abstract][Full Text] [Related]
6. Mood disorders are highly prevalent in patients investigated with a multiple sleep latency test. Denton EJ; Barnes M; Churchward T; Jackson M; Collins A; Naughton MT; Dabscheck E Sleep Breath; 2018 May; 22(2):305-309. PubMed ID: 28993975 [TBL] [Abstract][Full Text] [Related]
7. End of dose interval symptoms in patients treated with natalizumab: A role for serum cytokines? Cathérine D; Annelien P; Anne S; Luc A; Liesbeth VH; Gerlo S; Guy L Mult Scler Relat Disord; 2020 Jun; 41():102020. PubMed ID: 32146430 [TBL] [Abstract][Full Text] [Related]
8. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Côté I; Trojan DA; Kaminska M; Cardoso M; Benedetti A; Weiss D; Robinson A; Bar-Or A; Lapierre Y; Kimoff RJ Mult Scler; 2013 Apr; 19(4):480-9. PubMed ID: 22914848 [TBL] [Abstract][Full Text] [Related]
9. Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study. Wilken J; Kane RL; Sullivan CL; Gudesblatt M; Lucas S; Fallis R; You X; Foulds P Int J MS Care; 2013; 15(3):120-8. PubMed ID: 24453774 [TBL] [Abstract][Full Text] [Related]
10. Underperception of Naps in Older Adults Referred for a Sleep Assessment: An Insomnia Trait and a Cognitive Problem? Nguyen-Michel VH; Lévy PP; Pallanca O; Kinugawa K; Banica-Wolters R; Sebban C; Mariani J; Fournier E; Arnulf I J Am Geriatr Soc; 2015 Oct; 63(10):2001-7. PubMed ID: 26415517 [TBL] [Abstract][Full Text] [Related]
11. Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data. Veauthier C; Gaede G; Radbruch H; Wernecke KD; Paul F Sleep Disord; 2016; 2016():8378423. PubMed ID: 26885399 [TBL] [Abstract][Full Text] [Related]
12. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Kaminska M; Kimoff RJ; Benedetti A; Robinson A; Bar-Or A; Lapierre Y; Schwartzman K; Trojan DA Mult Scler; 2012 Aug; 18(8):1159-69. PubMed ID: 22183937 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766 [TBL] [Abstract][Full Text] [Related]
15. Excessive daytime sleepiness and fatigue in depressed patients and therapeutic response of a sedating antidepressant. Shen J; Hossain N; Streiner DL; Ravindran AV; Wang X; Deb P; Huang X; Sun F; Shapiro CM J Affect Disord; 2011 Nov; 134(1-3):421-6. PubMed ID: 21616541 [TBL] [Abstract][Full Text] [Related]
16. Daytime Sleepiness in Adults With ADHD: A Pilot Trial With a Multiple Sleep Latency Test. Sobanski E; Alm B; Hennig O; Riemann D; Feige B; Schredl M J Atten Disord; 2016 Dec; 20(12):1023-1029. PubMed ID: 24743976 [TBL] [Abstract][Full Text] [Related]
17. Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric study. Planche V; Moisset X; Morello R; Dumont E; Gibelin M; Charré-Morin J; Saubusse A; Mondou A; Reuter F; Defer G; Pelletier J; Brochet B; Clavelou P J Neurol Sci; 2017 Nov; 382():148-154. PubMed ID: 29111011 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients. Gavrilov YV; Shkilnyuk GG; Valko PO; Stolyarov ID; Ivashkova EV; Ilves AG; Nikiforova IG; Shchelkova OY; Vasserman LI; Vais EE; Valko Y Acta Neurol Scand; 2018 Nov; 138(5):408-416. PubMed ID: 29984406 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle. Ratchford JN; Brock-Simmons R; Augsburger A; Steele SU; Mohn K; Rhone M; Bo J; Costello K Int J MS Care; 2014; 16(2):92-8. PubMed ID: 25061433 [TBL] [Abstract][Full Text] [Related]
20. The Brugmann Fatigue Scale: An Analogue to the Epworth Sleepiness Scale to Measure Behavioral Rest Propensity. Mairesse O; Damen V; Newell J; Kornreich C; Verbanck P; Neu D Behav Sleep Med; 2019; 17(4):437-458. PubMed ID: 29065269 [No Abstract] [Full Text] [Related] [Next] [New Search]